• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

30 岁女性低级别富马酸水合酶缺陷型肾细胞癌。

Low-Grade Fumarate Hydratase-Deficient Renal Cell Carcinoma in a 30-Year-Old Female.

机构信息

1861Brigham and Women's Hospital and 1811Harvard Medical School, Boston, MA, USA.

6470Kaiser Foundation Hospital, 158530Southern California Permanente Medical Group, Baldwin Park, CA, USA.

出版信息

Int J Surg Pathol. 2022 Apr;30(2):184-189. doi: 10.1177/10668969211026241. Epub 2021 Jun 28.

DOI:10.1177/10668969211026241
PMID:34180725
Abstract

Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare and clinically aggressive RCC subtype that is commonly associated with the hereditary leiomyomatosis and renal cell carcinoma syndrome. The diagnostic hallmark of FH-deficient RCC is a high-grade microscopic appearance with prominent inclusion-like eosinophilic nucleoli and perinucleolar halos. Herein we report a case of an FH-deficient RCC in a 30-year-old female that exhibited low-grade nuclei and abundant eosinophilic cytoplasm, reminiscent of the clinically more indolent succinate dehydrogenase-deficient RCC subtype and the newly described eintity, eosinophilic, solid and cystic RCC. This case illustrates that FH-deficient RCC can have a wide spectrum of microscopic appearances, including low-grade eosinophilic RCC. In addition, it highlights that a low threshold to perform the immunohistochemical stains for FH and S-(2-succino) cysteine is warranted in RCC cases with unusual and even low-grade eosinophilic morphology.

摘要

琥珀酸脱氢酶(FH)缺陷型肾细胞癌(RCC)是一种罕见且临床侵袭性较强的 RCC 亚型,通常与遗传性平滑肌瘤病和肾细胞癌综合征相关。FH 缺陷型 RCC 的诊断标志是具有高级别微观外观,突出的包涵体样嗜酸性核仁以及核周晕。在此,我们报告了一例 30 岁女性的 FH 缺陷型 RCC,其表现为低级别核,富含嗜酸性细胞质,类似于临床上惰性更强的琥珀酸脱氢酶缺陷型 RCC 亚型和新描述的实体,嗜酸性、实性和囊性 RCC。该病例说明 FH 缺陷型 RCC 可能具有广泛的微观表现,包括低级别嗜酸性 RCC。此外,它强调在具有不寻常甚至低级别嗜酸性形态的 RCC 病例中,有必要进行 FH 和 S-(2-琥珀酸)半胱氨酸的免疫组织化学染色,以降低门槛。

相似文献

1
Low-Grade Fumarate Hydratase-Deficient Renal Cell Carcinoma in a 30-Year-Old Female.30 岁女性低级别富马酸水合酶缺陷型肾细胞癌。
Int J Surg Pathol. 2022 Apr;30(2):184-189. doi: 10.1177/10668969211026241. Epub 2021 Jun 28.
2
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.延胡索酸水合酶缺陷型肾细胞癌与延胡索酸水合酶突变及遗传性平滑肌瘤病和肾细胞癌综合征密切相关。
Am J Surg Pathol. 2016 Jul;40(7):865-75. doi: 10.1097/PAS.0000000000000617.
3
A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.一种具有独特形态学特征的低级别嗜酸细胞瘤性富马酸水合酶缺陷型肾细胞癌,类似于琥珀酸脱氢酶缺陷型肾细胞癌。
Histopathology. 2017 Jul;71(1):42-52. doi: 10.1111/his.13183. Epub 2017 Apr 12.
4
Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration.模式多样性以及富马酸水合酶(FH)/S-(2-琥珀酰)半胱氨酸(2SC)染色,但缺乏嗜酸性核仁伴核周晕,可将遗传性平滑肌瘤病和肾细胞癌相关的肾细胞癌与不伴有 FH 基因突变的肾脏肿瘤区分开来。
Mod Pathol. 2018 Jun;31(6):974-983. doi: 10.1038/s41379-018-0017-7. Epub 2018 Feb 6.
5
Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases.富马酸水合酶缺乏性肾细胞癌和富马酸水合酶缺乏样肾细胞癌:23例基因检测病例的形态学比较研究
Cesk Patol. 2019 Fall;55(4):244-249.
6
Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms.琥珀酸脱氢酶缺陷型肾细胞癌:7 例包括遗传性和散发性病例的临床病理研究。
Ann Diagn Pathol. 2020 Dec;49:151599. doi: 10.1016/j.anndiagpath.2020.151599. Epub 2020 Aug 24.
7
Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases.琥珀酸脱氢酶缺陷型肾细胞癌:13 例临床病理与分子研究。
J Clin Pathol. 2019 Nov;72(11):748-754. doi: 10.1136/jclinpath-2019-205924. Epub 2019 Jul 1.
8
Fumarate hydratase-deficient renal cell carcinoma: an oncology care institutional experience.琥珀酸脱氢酶缺陷型肾细胞癌:肿瘤学治疗机构的经验。
APMIS. 2024 Aug;132(8):544-552. doi: 10.1111/apm.13425. Epub 2024 May 22.
9
Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors.低级别嗜酸细胞瘤性富马酸水合酶缺失性肾细胞癌:生物学潜能、形态谱的最新研究及与其他低级别嗜酸细胞瘤性肿瘤的鉴别诊断。
Adv Anat Pathol. 2021 Nov 1;28(6):396-407. doi: 10.1097/PAP.0000000000000321.
10
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses.遗传性平滑肌瘤病和肾细胞癌综合征相关肾细胞癌:形态学评估及鉴别诊断综合综述
Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S7-S17. doi: 10.4103/IJPM.IJPM_877_19.

引用本文的文献

1
Clinicopathological and molecular features of so-called low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma: a study of 5 cases.所谓低级别富马酸水合酶缺乏性嗜酸细胞肾细胞癌的临床病理及分子特征:5例病例研究
Virchows Arch. 2025 Apr 30. doi: 10.1007/s00428-025-04111-8.
2
Case report: A rare low-grade fumarate hydratase-deficient renal cell carcinoma.病例报告:一例罕见的低级别富马酸水合酶缺陷型肾细胞癌。
Front Oncol. 2024 Nov 26;14:1440119. doi: 10.3389/fonc.2024.1440119. eCollection 2024.
3
Ferroptosis: a promising target for fumarate hydratase-deficient tumor therapeutics literature review.
铁死亡:富马酸水合酶缺陷型肿瘤治疗的一个有前景的靶点文献综述
Transl Cancer Res. 2024 Jun 30;13(6):3126-3141. doi: 10.21037/tcr-24-21. Epub 2024 Jun 27.